Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 09, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Amgen Inc. (NASDAQ: AMGN)...
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 04, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Amgen Inc. (NASDAQ: AMGN)...
-
SAN DIEGO, March 30, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise...
-
SAN DIEGO, March 24, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise...
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 20, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Amgen Inc. (NASDAQ: AMGN)...
-
SAN DIEGO, March 17, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise...
-
LOS ANGELES, May 03, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Amgen Inc. ("Amgen" or "the Company") (NASDAQ: AMGN) investors that the firm has initiated an investigation into possible...